⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Taurus Large Cap Fund - Growth - Direct Plan | Kotak Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | — | Kotak MF |
| Category | Equity - Large Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹177.24 (30 Oct 2026) | ₹17.44 (30 Oct 2026) |
| Rating | ★★★★★ | ★★★ |
| Benchmark | BSE 100 - TRI | Nifty Healthcare Index - TRI |
| Fund Manager | Anuj Kapil | Dhananjay Tikariha |
| Inception | 01 Jan 2013 | 11 Dec 2023 |
| Returns | ||
| 1Y | 2.96% | 23.31% |
| 3Y | 14.18% | — |
| 5Y | 10.14% | — |
| Since Inception | 10.55% | 21.25% |
| Risk | ||
| 12.84 | 14.88 | |
| 0.91 | 0.99 | |
| 0.52 | 1.02 | |
| 6.27 | 3.82 | |
| 1.01 | 2.12 | |
| -9.28% | -11.03% | |
| Costs | ||
| Expense Ratio | 2.54% | 1.04% |
| Exit Load | 1% on or before 365D, Nil after 365D | 0.50% on or before 30D, Nil after 30D |
| Min SIP | ₹1,000 | ₹100 |
| Min Lumpsum | ₹500 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Taurus Large …91%
Kotak MF91%
8.7%Only 8.7% of holdings by weight are common between Taurus Large Cap Fund - Growth - Direct Plan and Kotak MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingTaurus Large Cap Fund - Growth - Direct PlanKotak MF
Divi's Laboratories Ltd.8.72%9.35%
Category context: Equity vs Equity. Open the full Screener →